107 related articles for article (PubMed ID: 3044582)
21. The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells.
Jelinek DF; Lipsky PE
J Immunol; 1985 Mar; 134(3):1690-701. PubMed ID: 3871457
[TBL] [Abstract][Full Text] [Related]
22. Avemar, a nontoxic fermented wheat germ extract, induces apoptosis and inhibits ribonucleotide reductase in human HL-60 promyelocytic leukemia cells.
Saiko P; Ozsvar-Kozma M; Madlener S; Bernhaus A; Lackner A; Grusch M; Horvath Z; Krupitza G; Jaeger W; Ammer K; Fritzer-Szekeres M; Szekeres T
Cancer Lett; 2007 Jun; 250(2):323-8. PubMed ID: 17137710
[TBL] [Abstract][Full Text] [Related]
23. Cell differentiation and cell cycle effects on human promyelocytic leukemia cells induced by 12-O-tetradecanoylphorbol-13-acetate.
Yun K; Sugihara H
Lab Invest; 1986 Mar; 54(3):336-44. PubMed ID: 3456469
[TBL] [Abstract][Full Text] [Related]
24. Activities of both ribonucleotide reductase subunits, M1 and M2, decrease upon serum starvation of baby hamster kidney 21/C13 cells.
Cohen EA; Filion M; Suh M; Langelier Y
Biochem Cell Biol; 1987 Jan; 65(1):35-42. PubMed ID: 3552001
[TBL] [Abstract][Full Text] [Related]
25. Alteration of cell cycle progression in human leukemia cell line (KOPM-28) induced by 12-o-tetradecanoylphorbol-13-acetate.
Tsuda H; Sakaguchi M; Kawakita M; Nakazawa S; Mori T; Takatsuki K
Int J Cell Cloning; 1988 May; 6(3):209-20. PubMed ID: 3397593
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of HL-60 promyelocytic leukemia cells: simultaneous determination of phagocytic activity and cell cycle distribution by flow cytometry.
Blair OC; Carbone R; Sartorelli AC
Cytometry; 1986 Mar; 7(2):171-7. PubMed ID: 3456296
[TBL] [Abstract][Full Text] [Related]
27. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts.
LaRue KE; Bradbury EM; Freyer JP
Cancer Res; 1998 Mar; 58(6):1305-14. PubMed ID: 9515820
[TBL] [Abstract][Full Text] [Related]
29. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
[TBL] [Abstract][Full Text] [Related]
30. Early decline in c-myb oncogene expression in the differentiation of human myeloblastic leukemia (ML-1) cells induced with 12-O-tetradecanoylphorbol-13-acetate.
Craig RW; Bloch A
Cancer Res; 1984 Feb; 44(2):442-6. PubMed ID: 6198073
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle progression and phenotypic modification of Ki67 antigen-negative G1- and G2-phase cells in phorbol ester-treated Molt-4 human leukemia cells.
Tsurusawa M; Fujimoto T
Cytometry; 1995 Jun; 20(2):146-53. PubMed ID: 7664625
[TBL] [Abstract][Full Text] [Related]
32. Ribonucleotide reductase in cultured mouse lymphoma cells. Cell cycle-dependent variation in the activity of subunit protein M2.
Eriksson S; Martin DW
J Biol Chem; 1981 Sep; 256(18):9436-40. PubMed ID: 6270086
[TBL] [Abstract][Full Text] [Related]
33. WT1 protein expression in slowly proliferating myeloid leukemic cell lines is scarce throughout the cell cycle with a minimum in G0/G1 phase.
Kerst G; Bergold N; Viebahn S; Gieseke F; Kalinova M; Trka J; Handgretinger R; Müller I
Leuk Res; 2008 Sep; 32(9):1393-9. PubMed ID: 18457871
[TBL] [Abstract][Full Text] [Related]
34. Bivariate flow cytometric analysis of DNA content versus immunopositivity for ribonucleotide reductase M1 subunit in the cell cycle.
Mangiarotti R; Bottone MG; Danova M; Pellicciari C
Cytometry; 1998 Jun; 32(2):78-85. PubMed ID: 9627220
[TBL] [Abstract][Full Text] [Related]
35. Ribonucleotide reductase--new twists in an old tale.
Whitfield JF; Sikorska M; Youdale T; Brewer L; Richards R; Walker PR
Adv Enzyme Regul; 1989; 28():113-23. PubMed ID: 2696342
[TBL] [Abstract][Full Text] [Related]
36. Ribonucleotide reductase activity and deoxyribonucleoside triphosphate metabolism during the cell cycle of S49 wild-type and mutant mouse T-lymphoma cells.
Albert DA; Gudas LJ
J Biol Chem; 1985 Jan; 260(1):679-84. PubMed ID: 2981227
[TBL] [Abstract][Full Text] [Related]
37. Different quiescence states of three culture cell lines detected by acridine orange staining of cellular RNA.
Baisch H
Cytometry; 1988 Jul; 9(4):325-31. PubMed ID: 2456898
[TBL] [Abstract][Full Text] [Related]
38. Transient elevation of ribonucleotide reductase activity, M2 mRNA and M2 protein in BALB/c 3T3 fibroblasts in the presence of 12-O-tetradecanoylphorbol-13-acetate.
Choy BK; McClarty GA; Wright JA
Biochem Biophys Res Commun; 1989 Aug; 162(3):1417-24. PubMed ID: 2669751
[TBL] [Abstract][Full Text] [Related]
39. Demonstration of normal and mutant protein M1 subunits of deoxyGTP-resistant ribonucleotide reductase from mutant mouse lymphoma cells.
Ullman B; Gudas LJ; Caras IW; Eriksson S; Weinberg GL; Wormsted MA; Martin DW
J Biol Chem; 1981 Oct; 256(19):10189-92. PubMed ID: 7024266
[TBL] [Abstract][Full Text] [Related]
40. A cell cycle analysis of growth-related genes expressed during T lymphocyte maturation.
Feder JN; Guidos CJ; Kusler B; Carswell C; Lewis D; Schimke RT
J Cell Biol; 1990 Dec; 111(6 Pt 1):2693-701. PubMed ID: 2277081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
